285 related articles for article (PubMed ID: 29214735)
1. The mechanism study of miR-125b in occurrence and progression of multiple myeloma.
Gao D; Xiao Z; Li HP; Han DH; Zhang YP
Cancer Med; 2018 Jan; 7(1):134-145. PubMed ID: 29214735
[TBL] [Abstract][Full Text] [Related]
2. LncRNA MALAT1/miR-181a-5p affects the proliferation and adhesion of myeloma cells via regulation of Hippo-YAP signaling pathway.
Sun Y; Jiang T; Jia Y; Zou J; Wang X; Gu W
Cell Cycle; 2019 Oct; 18(19):2509-2523. PubMed ID: 31397203
[TBL] [Abstract][Full Text] [Related]
3. LncRNA-MALAT1 promotes tumorogenesis of infantile hemangioma by competitively binding miR-424 to stimulate MEKK3/NF-κB pathway.
Li MM; Dong CX; Sun B; Lei HZ; Wang YL; Gong YB; Sun LL; Sun ZW
Life Sci; 2019 Dec; 239():116946. PubMed ID: 31610202
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA MALAT1 promotes oral squamous cell carcinoma development via microRNA-125b/STAT3 axis.
Chang SM; Hu WW
J Cell Physiol; 2018 Apr; 233(4):3384-3396. PubMed ID: 28926115
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of long non-coding RNA MALAT1 elevates microRNA-429 to suppress the progression of hypopharyngeal squamous cell carcinoma by reducing ZEB1.
Liu X; Zhao W; Wang X
Life Sci; 2020 Dec; 262():118480. PubMed ID: 32980391
[TBL] [Abstract][Full Text] [Related]
6. LncRNA NEAT1 affects inflammatory response by targeting miR-129-5p and regulating Notch signaling pathway in epilepsy.
Wan Y; Yang ZQ
Cell Cycle; 2020 Feb; 19(4):419-431. PubMed ID: 31948324
[TBL] [Abstract][Full Text] [Related]
7. MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells.
Shi B; Wang Y; Yin F
Cancer Biol Ther; 2017 Oct; 18(10):792-800. PubMed ID: 28857668
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA miR-188-5p as a mediator of long non-coding RNA MALAT1 regulates cell proliferation and apoptosis in multiple myeloma.
Liu H; Chi Z; Jin H; Yang W
Bioengineered; 2021 Dec; 12(1):1611-1626. PubMed ID: 33944676
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA MALAT1 facilitates the tumorigenesis, invasion and glycolysis of multiple myeloma via miR-1271-5p/SOX13 axis.
Liu N; Feng S; Li H; Chen X; Bai S; Liu Y
J Cancer Res Clin Oncol; 2020 Feb; 146(2):367-379. PubMed ID: 31953613
[TBL] [Abstract][Full Text] [Related]
10. LncRNA
Ye W; Ma J; Wang F; Wu T; He M; Li J; Pei R; Zhang L; Wang Y; Zhou J
Oxid Med Cell Longev; 2020; 2020():8184314. PubMed ID: 33274006
[TBL] [Abstract][Full Text] [Related]
11. LncRNA-MALAT1 promotes neovascularization in diabetic retinopathy through regulating miR-125b/VE-cadherin axis.
Liu P; Jia SB; Shi JM; Li WJ; Tang LS; Zhu XH; Tong P
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988072
[No Abstract] [Full Text] [Related]
12. LncRNA MALAT1 modified progression of clear cell kidney carcinoma (KIRC) by regulation of miR-194-5p/ACVR2B signaling.
Ye Y; Zhang F; Chen Q; Huang Z; Li M
Mol Carcinog; 2019 Feb; 58(2):279-292. PubMed ID: 30334578
[TBL] [Abstract][Full Text] [Related]
13. Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long non-coding RNA MALAT1.
Han Y; Liu Y; Zhang H; Wang T; Diao R; Jiang Z; Gui Y; Cai Z
FEBS Lett; 2013 Nov; 587(23):3875-82. PubMed ID: 24396870
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.
Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC
Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846
[TBL] [Abstract][Full Text] [Related]
15. LncRNA MALAT1 promotes epithelial-to-mesenchymal transition of esophageal cancer through Ezh2-Notch1 signaling pathway.
Chen M; Xia Z; Chen C; Hu W; Yuan Y
Anticancer Drugs; 2018 Sep; 29(8):767-773. PubMed ID: 29916899
[TBL] [Abstract][Full Text] [Related]
16. Long Non-coding RNA MALAT1 Inhibits Neuron Apoptosis and Neuroinflammation While Stimulates Neurite Outgrowth and Its Correlation With MiR-125b Mediates PTGS2, CDK5 and FOXQ1 in Alzheimer's Disease.
Ma P; Li Y; Zhang W; Fang F; Sun J; Liu M; Li K; Dong L
Curr Alzheimer Res; 2019; 16(7):596-612. PubMed ID: 31345147
[TBL] [Abstract][Full Text] [Related]
17. Long non‑coding RNA MALAT1 correlates with cell viability and mobility by targeting miR‑22‑3p in renal cell carcinoma via the PI3K/Akt pathway.
Li Z; Ma Z; Xu X
Oncol Rep; 2019 Feb; 41(2):1113-1121. PubMed ID: 30431104
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of
Hu Z; Liu X; Guo J; Zhuo L; Chen Y; Yuan H
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34713294
[TBL] [Abstract][Full Text] [Related]
19. LncRNA-MEG3 inhibits cell proliferation of endometrial carcinoma by repressing Notch signaling.
Guo Q; Qian Z; Yan D; Li L; Huang L
Biomed Pharmacother; 2016 Aug; 82():589-94. PubMed ID: 27470401
[TBL] [Abstract][Full Text] [Related]
20. LncRNA HCG11/miR-579-3p/MDM2 axis modulates malignant biological properties in pancreatic carcinoma via Notch/Hes1 signaling pathway.
Xu J; Xu W; Yang X; Liu Z; Sun Q
Aging (Albany NY); 2021 Jun; 13(12):16471-16484. PubMed ID: 34230221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]